| |
Group
|
Study initiation(months)
|
Between-Subjects Effects
|
|---|
|
0
|
3
|
6
|
F
|
P
|
|---|
|
CD4%
|
Control (n = 4)
|
33.94 ± 8.49
|
34.16 ± 1.99
|
25.02 ± 7.28
|
12.252
|
0.004**
|
|
LTNP (n = 4)
|
27.17 ± 5.79
|
23.77 ± 6.20
|
20.09 ± 4.78
|
|
Progressors (n = 4)
|
17.12 ± 5.09
|
15.52 ± 5.46
|
13.41 ± 4.55
|
|
CD8%
|
Control (n = 4)
|
21.37 ± 5.60
|
22.61 ± 3.01
|
17.25±2.47
|
3.453
|
0.083
|
|
LTNP (n = 4)
|
41.62 ± 16.47
|
33.24 ± 8.03
|
31.35 ± 8.20
|
|
Progressors (n = 4)
|
35.54 ± 11.45
|
26.10 ± 5.05
|
31.26 ± 10.91
|
|
CD4/CD8
|
Control (n = 4)
|
1.6 ± 0.22
|
1.52 ± 0.14
|
1. 43±0.25
|
40.946
|
0.000**
|
|
LTNP (n = 4)
|
0.75 ± 0.32
|
0.76 ± 0.31
|
0.66 ± 0.11
|
|
Progressors (n = 4)
|
0.49 ± 0.11
|
0.59 ± 0.20
|
0. 48 ± 0.29
|
- **,P < 0.01 in the Analysis of variance (ANOVA) for Repeated Measures
